Navigation Links
Francesco Granata, M.D. Joins Board of Prismic Pharmaceuticals
Date:12/3/2013

SCOTTSDALE, Ariz., Dec. 3, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based, commercial-stage pharmaceutical company focused on prescription Medical Foods, today announced the election of Francesco Granata, M.D., to its Board of Directors.

Dr. Granata is currently Executive in Residence at Warburg Pincus, a leading private equity firm focused on growth investing.  He is an accomplished healthcare executive with more than 35 years of experience in the international pharmaceutical and biotechnology industries.  Before joining Warburg Pincus, Dr. Granata held senior management positions at Pfizer, where he was President of the Northern Europe region; Schering-Plough, where he served as Group Vice President and President for the Europe and Canada region; and most recently at Biogen Idec Inc., where he was Executive Vice President of Global Commercial Operations, with responsibility for worldwide Commercial Operations and Medical Affairs.  Dr. Granata is also a Board Member of Circassia, a UK-based specialty Biopharmaceutical company and Italfarmaco, one of Italy's leading international pharmaceutical groups. 

"Francesco Granata has had an exceptionally successful career and brings a wealth of healthcare experience and strategic vision to our Board of Directors," commented Peter Moriarty, Chairman and CEO of Prismic.  "Prior to joining the pharmaceutical industry, Francesco practiced as a physician and surgeon, specializing in Cardiology.  He has also been Chairman of the European Committee of the Pharmaceutical Research and Manufacturers Association of America and Co-Chairman of the Heads of Europe Committee of the European Federation of Pharmaceutical Industries and Associations.  We are honored that he has accepted the invitation to join our Board.  We are confident of the contribution he will make in helping the Board to guide Prismic's continuing path to commercial success and increased value for our shareholders."  

"Prismic has an extremely interesting and innovative portfolio of patent-protected products," stated Dr. Granata. "I believe that the company has identified products and market opportunities that are medically important as well as commercially very attractive. Prismic has the choice of exploiting those opportunities alone or in partnership with other commercial entities in the United States and Internationally.  I look forward to working with my fellow Board members to help Management drive optimum value for our shareholders."

About Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc., is a privately held, commercial-stage pharmaceutical company focused on the development and marketing of prescription Medical Foods for the clinical dietary management of the metabolic processes associated with many of the disorders associated with the aging population, particularly where inflammation is involved.  The company, founded in 2011, is headquartered in Scottsdale, Arizona, with offices in Boston, USA, and London, England. Contact 480.422.1810 or visit www.PrismicPharma.com.

INFORMATION CONTACT
Peter Moriarty
Tel: 480.422.1810


'/>"/>
SOURCE Prismic Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
2. Guri Stark Joins CorTechs Labs as CEO
3. Eisai Joins Groundbreaking Tuberculosis Drug Accelerator Partnership to Discover New Tuberculosis Drugs
4. BD Joins National Patient Safety Foundation Corporate Council, Furthers Commitment to Safety
5. Rafarma Pharmaceuticals, Inc. (RAFA) Joins in Economic Development Coalition to Increase Biotech Growth in Terbuny, Russia.
6. Helping New Yorkers Prevent Heart Attacks: Itamar Medical Joins The Fight With New Campaign
7. Bay Alarm Medical Joins The Fight To End Hunger
8. Chris Newmarker joins MPMN and Qmed
9. State Senator Mae Beavers Joins Local Leaders, Retailers, Pharmacists To Launch Anti-Smurfing Public Awareness Campaign
10. Jefferson School of Population Health joins the Alliance for Rational Use of NSAIDs
11. RidgeCrest Herbals New Thyroid Thrive Joins Companys List Of Top 10 Bestsellers In Record Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):